We are monitoring the impact of COVID-19 on Europe Blood Screening Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 3177
Share on
Share on

Europe Blood Screening Market Research Report – Segmented By Technology, Product & End User, By Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2020 to 2025)

Pulished: February, 2020
ID: 3177
Pages: 148

Europe Blood Screening Market Size (2020 to 2025)

According to the report, the Europe Blood Screening Market size is valued at USD 0.52 billion in 2020 and is expected to reach USD 0.8 billion by 2025, growing at a CAGR of 9.1% during the forecast period.

The factors contributing to market growth for the blood screening market in European countries are aware of blood donation drives and safe procedures and quality assurance systems. European countries made blood screening procedures compulsory for various diseases like HIV, Cancers, HBV, and HSV. An increase in occurrences of diseases and irresistible infections are anticipated to enlarge the market advancement in the coming years. Rigid government guidelines concerning the screening are considered and executed in action. Tolerant security is foreseen to push market development additionally. The ascent in the quantity of complex medical procedures performed, such as chemotherapy, heart medical procedure, and organ relocate, which require an enormous number of blood tests, is likewise prone to affect the market positively.

Along with the market growth factors, the blood screening market has to undergo some restraints which held back the market’s growth. European countries are considered developing countries, and hence the rise in population is also observed. More the population means more the spread of infection rate. Therefore, infection control through blood transfusion procedures is not possible, and this is to be regulated and controlled. And there are strict regulation bodies to provide approval, and this hampers the market growth. The blood screening market needs a lot of workforce in various divisions, and the lack of skilled persons also holds back the market growth. The European nation is one of the technologically developed regions, where alternative techniques for blood screening are on demand. It hampers the market growth.

Covid-19 Impact on the market:

Due to COVID lockdown and travel ban issues, there’s a significant impact on lab tests being performed for patients. Also, there’s a lot of loss in skilled staff and human resources, which impacted groundwork. It has been difficult for people who cannot get access to clinics or diagnostic centers. The exports and imports of materials, goods, and devices required for the market have been halted. The loss of pay is considerably noted for the staff and health workers in the market.

Europe Blood Screening Market has been segmented and sub-segmented into the following categories

  • By Technology: Nucleic Acid Amplification, Elisa, Rapid Test, NGS, and Western Blotting.
  • By Product: Instrument, Reagent & Kits, and Software.
  • By End User: Blood bank and Hospital.
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe.

European nations have made it compulsory for every citizen for blood screening for HIV, HBV, HCV, parvovirus 19, and different infections. The blood screening administrations in Germany are directed by the International Red Cross, the Code of International Society of Blood Transfusion, and the German Transfusion Act. In France, the French Blood Establishment (EFS) directs the assortment, planning, testing, and circulation of labile blood items. 

Whereas in Italy, the National Blood Center (NBC), a well-being service division, regulates the coordination of specialized and logical control of the blood framework.

Prominent Companies dominating the Europe Blood Screening Market Profiled in the Report are Becton, Dickinson and Company, Thermo Fisher Scientific Inc, Ortho Clinical Diagnostics, Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories, Inc, F. Hoffmann-La Roche Ltd, Grifols, Siemens AG and Beckman Coulter, Inc.

1.Introduction            

                1.1 Market Definition       

                1.2 Study Deliverables     

                1.3 Base Currency, Base Year and Forecast Periods    

                1.4 General Study Assumptions   

2. Research Methodology  

                2.1 Introduction         

                2.2 Research Phases

   2.2.1 Secondary Research                           

   2.2.2 Primary Research                 

   2.2.3 Econometric Modelling                      

   2.2.4 Expert Validation                  

                2.3 Analysis Design   

                2.4 Study Timeline    

3. Overview                 

                3.1 Executive Summary   

                3.2 Key Inferences   

                3.3 Epidemology        

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)              

                4.1 Market Drivers    

                4.2 Market Restraints       

                4.3 Key Challenges   

                4.4 Current Opportunities in the Market        

5. Market Segmentation     

                5.1 Technology    

   5.1.1 Nucliec Acid Amplification Test                       

          6.3.1 Transcription-Mediated Amplification (TMA)           

          6.3.2 Real-Time Polymerase Chain Reaction (PCR             

   5.1.2 rCPR                           

   5.1.3 ELISA                         

          5.1.3.1 ELISA Market, By Platform            

    5.1.3.1.1 Chemiluminescence Immunoassay (CLIA)

    5.1.3.1.2 Fluorescence Immunoassay (FIA)

   5.1.3.1.3 Colorimetric Immunoassay (CI)

          5.1.3.2 ELISA Market, By Generation      

   5.1.3.2.1 First-Generation ELISA

   5.1.3.2.2 Second-Generation ELISA

   5.1.3.2.3 Third-Generation ELISA

   5.1.3.2.4 Fourth-Generation & Above

   5.1.4 CLIA                           

   5.1.5 Flourescence Assay

   5.1.6 Rapid Test  

   5.1.7 NGS                           

   5.1.8 Western Blotting                  

   5.1.9  Y-o-Y Growth Analysis, By Technology                       

   5.1.10  Market Attractiveness Analysis, By Technology                   

   5.1.11  Market Share Analysis, By Technology                    

                5.2 Product  

   5.2.1 Instrument

          5.2.1.1 Rental Purchase

          5.2.1.2 Outright Purchase            

   5.2.2 Reagent and Kits                  

          5.2.2.1 NAT Reagents & Kits       

   5.2.2.1.1 Enzymes and Polymerases

   5.2.2.1.2 Standards and Controls

   5.2.2.1.3 Probes and Primers

   5.2.2.1.4 Buffers, Nucleotides and Solutions

   5.2.2.1.5 Labeling and Detection Reagents

          5.2.2.2 ELISA Reagents & Kits     

   5.2.2.2.1 Immunosorbents

    5.2.2.2.2 Controls

   5.2.2.2.3 Conjugates (Antigen Or Antibody-Conjugated Enzyme)

   5.2.2.2.4 Substrates (Of Enzymes)

   5.2.2.2.5 Sample Diluents and Wash Solutions

   5.2.3 Software                  

   5.2.4 Y-o-Y Growth Analysis, By Product  

   5.2.5 Market Attractiveness Analysis, By Product

   5.2.6 Market Share Analysis, By Product  

                5.3 End User

   5.3.1 Blood Bank 

   5.3.2 Hospital                    

   5.3.3 Y-o-Y Growth Analysis, By End User

   5.3.4  Market Attractiveness Analysis, By End User                          

   5.3.5  Market Share Analysis, By End User                            

   5.3.9  Market Share Analysis, By Application                       

6. Geographical Analysis     

                6.1 Introduction         

   6.1.1 Regional Trends                    

   6.1.2 Impact Analysis                     

   6.1.3 Y-o-Y Growth Analysis                        

          6.1.3.1 By Geographical Area     

          6.1.3.2 By Technology   

          6.1.3.3 By Product           

          6.1.3.4 By End User        

   6.1.4  Market Attractiveness Analysis                     

          6.1.4.1 By Geographical Area     

          6.1.4.2 By Technology   

          6.1.4.3 By Product           

          6.1.4.4 By End User        

   6.1.5  Market Share Analysis                      

          6.1.5.1 By Geographical Area     

          6.1.5.2 By Technology   

          6.1.5.3 By Product           

          6.1.5.4 By End User        

                6.2 U.K    

                6.3 Spain       

                6.4 Germany        

                6.5 Italy         

                6.6 France    

7.Strategic Analysis                  

                7.1 PESTLE analysis   

   7.1.1 Political                     

   7.1.2 Economic                 

   7.1.3 Social                         

   7.1.4 Technological                         

   7.1.5 Legal                          

   7.1.6 Environmental                       

                7.2 Porter’s Five analysis        

   7.2.1 Bargaining Power of Suppliers                        

   7.2.2 Bargaining Power of Consumers                    

   7.2.3 Threat of New Entrants                     

   7.2.4 Threat of Substitute Products and Services 

   7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis

                8.1 Grifols     

   8.1.1 Overview                 

   8.1.2 Product Analysis                   

   8.1.3 Financial analysis                  

   8.1.4 Recent Developments                       

   8.1.5 SWOT analysis                       

   8.1.6 Analyst View                          

                8.2 Thermo Fisher Scientific  

                8.3 Roche Diagnostics       

                8.4 BioMerieux   

                8.5 Bio-Rad Laboratories        

                8.6 Siemens Heathineers       

                8.7 Abbott Laboratories         

                8.8 Ortho Clinical diagnostics

                8.9 Becton    

                8.10 Dickinson and Company        

                8.11 Beckman Coulter      

9.Competitive Landscape   

                9.1 Market share analysis      

                9.2 Merger and Acquisition Analysis 

                9.3 Agreements, collaborations and Joint Ventures   

                9.4 New Product Launches   

10.Market Outlook and Investment Opportunities 

Appendix  

                a) List of Tables   

                b) List of Figures        

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Blood Screening Market, By Technology, From 2020 to 2025 (USD Million)
  2. Europe Nucliec Acid Amplification Market, By Region, From 2020 to 2025 (USD Million)
  3. Europe rCPR Market, By Region, From 2020 to 2025 (USD Million)
  4. Europe ELISA Market, By Region, From 2020 to 2025 (USD Million)
  5. Europe CLIA Market, By Region, From 2020 to 2025 (USD Million)
  6. Europe Flourescence Assay Market, By Region, From 2020 to 2025 (USD Million)
  7. Europe Rapid Test Market, By Region, From 2020 to 2025 (USD Million)
  8. Europe NGS Market, By Region, From 2020 to 2025 (USD Million)
  9. Europe Western Blotting Market, By Region, From 2020 to 2025 (USD Million)
  10. Europe Blood Screening Market, By Product, From 2020 to 2025 (USD Million)
  11. Europe Instrument Market, By Region, From 2020 to 2025 (USD Million)
  12. Europe Reagent and Kits Market, By Region, From 2020 to 2025 (USD Million)
  13. Europe Software Market, By Region, From 2020 to 2025 (USD Million)
  14. Europe Blood Screening Market, By End User, From 2020 to 2025 (USD Million)
  15. Europe Blood Bank Market, By Region, From 2020 to 2025 (USD Million)
  16. Europe Hospital Market, By Region, From 2020 to 2025 (USD Million)
  17. U.K. Blood Screening Market, By Technology, From 2020 to 2025 (USD Million)
  18. U.K. Blood Screening Market, By Product, From 2020 to 2025 (USD Million)
  19. U.K. Blood Screening Market, By End User, From 2020 to 2025 (USD Million)
  20. Germany Blood Screening Market, By Technology, From 2020 to 2025 (USD Million)
  21. Germany Blood Screening Market, By Product, From 2020 to 2025 (USD Million)
  22. Germany Blood Screening Market, By End User, From 2020 to 2025 (USD Million)
  23. France Blood Screening Market, By Technology, From 2020 to 2025 (USD Million)
  24. France Blood Screening Market, By Product, From 2020 to 2025 (USD Million)
  25. France Blood Screening Market, By End User, From 2020 to 2025 (USD Million)
  26. Italy Blood Screening Market, By Technology, From 2020 to 2025 (USD Million)
  27. Italy Blood Screening Market, By Product, From 2020 to 2025 (USD Million)
  28. Italy Blood Screening Market, By End User, From 2020 to 2025 (USD Million)
  29. Spain Blood Screening Market, By Technology, From 2020 to 2025 (USD Million)
  30. Spain Blood Screening Market, By Product, From 2020 to 2025 (USD Million)
  31. Spain Blood Screening Market, By End User, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample